Name PRICE MARKET CAPITALIZATION PRICE TO EARNINGS RATIO DIVIDEND YIELD SYMBOL EXCHANGE PRICE PERCENT DIFFERENCE YEAR TO DATE PRICE PERCENT DIFFERENCE 5 YEAR CHART 1 YEAR CHART

La Jolla Pharmaceutical Co is an American biopharmaceutical company. The company's main activity is the discovery, development, and commercialization of innovative therapies that improve patients' life-threatening conditions. The company's portfolio consists of an angiotensin II formulation, which regulates blood pressure; a formulation of hepcidin, an endogenous peptide hormone that regulates iron metabolism; and an antibiotic approved by the U.S. Food and Drug Administration.

http://www.ljpc.com

LJPC $6.74 +0.01 (0.15%)
Sector Health Care
Industry Biotech & Pharma
Market Cap 180 Million
EPS -1.70 P/E Ratio 0.00
Previous Earnings Wed, Aug 8, 2018
Latest Earnings Wed, Oct 24, 2018
Dividend --
Ex-Date --
Dividend Pay Date --
Dividend History --

6.74 0.18 0.00 0.00 LJPC NASDAQ 0.15 -32.53 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=LJPC&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=LJPC&exchange=NASDAQ&chart=1

Symbol Surfing has been referenced on Barrons, CNN & Investor Place.

About | Blog | Advertising | Terms | info@symbolsurfing.com

Investing Quotes #Legendary


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Some links on this website are advertisements and/or affiliate links and Symbol Surfing receives compensation.

©2019 Symbol Surfing All Rights Reserved. Privacy Policy | ^Top